Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000363758

Medchemexpress LLC Dalmelitinib | 1637658-98-0 | 98.7% | 461.47 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1472595MG

Encompass_Preferred

Dalmelitinib is an orally active, selective c-Met kinase inhibitor. It induces the phosphorylation of MET and partially or completely inhibits the phosphorylation of AKT and ERK. This compound potently inhibits the proliferation of cancer cells with c-Met oncogene amplification and is used for research in cancers such as human non-small cell lung cancer (NSCLC).

  • Orally active selective c-Met kinase inhibitor (IC50: 2.9 nM)
  • Binds to the ATP-binding region of c-Met
  • Inhibits cancer cell proliferation
  • Used for research in human non-small cell lung cancer

Catalog No. 50-003-63758


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.